Cogent Biosciences, Inc. (COGT)

Cogent Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	98.17	53.23	139.89	219.68	242.19
Short-Term Investments	188.91	212.48	119.39	-	-
Cash & Short-Term Investments	287.08	265.71	259.28	219.68	242.19
Cash Growth	8.04%	2.48%	18.02%	-9.29%	547.15%
Prepaid Expenses	9.4	5.06	4.44	2.95	2.72
Restricted Cash	-	-	1.26	-	-
Total Current Assets	296.47	270.77	264.97	222.63	244.91
Property, Plant & Equipment	26.56	30.34	31.1	4.48	4.75
Long-Term Investments	-	7.46	-	-	-
Other Long-Term Assets	4.86	4.86	4.75	4.98	1.26
Total Assets	327.9	313.44	300.81	232.09	250.92
Accounts Payable	12.01	10.66	5.84	3.48	0.73
Accrued Expenses	41.76	25.69	17.48	7.98	4.47
Current Portion of Leases	1.57	1.39	1.42	2.32	2.05
Other Current Liabilities	0.37	0.44	2.1	3.3	5.84
Total Current Liabilities	55.71	38.17	26.85	17.08	13.09
Long-Term Leases	15.9	17.47	18.23	0.83	3.16
Total Liabilities	71.61	55.64	45.08	17.91	16.25
Common Stock	0.11	0.09	0.07	0.04	0.03
Additional Paid-In Capital	1,005	801.06	601.15	399.71	322.45
Retained Earnings	-859.48	-603.62	-411.21	-270.97	-198.7
Comprehensive Income & Other	0.45	0.25	-0.1	-	-
Total Common Equity	145.69	197.77	189.91	128.78	123.79
Shareholders' Equity	256.29	257.8	255.74	214.18	234.67
Total Liabilities & Equity	327.9	313.44	300.81	232.09	250.92
Total Debt	17.47	18.85	19.65	3.16	5.21
Net Cash (Debt)	269.61	254.32	239.63	216.53	236.98
Net Cash Growth	6.01%	6.13%	10.67%	-8.63%	654.91%
Net Cash Per Share	2.59	3.19	4.07	5.59	21.39
Filing Date Shares Outstanding	110.54	103.91	69.95	45.81	37.19
Total Common Shares Outstanding	110.54	86.12	69.89	43.81	32.35
Working Capital	240.76	232.6	238.12	205.56	231.82
Book Value Per Share	1.32	2.30	2.72	2.94	3.83
Tangible Book Value	145.69	197.77	189.91	128.78	123.79
Tangible Book Value Per Share	1.32	2.30	2.72	2.94	3.83
Machinery	10.08	9.54	6.93	1.21	0.14
Construction In Progress	0.04	0.03	0.48	0.65	-
Leasehold Improvements	2.46	2.44	1.78	0.41	0.41

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q